[PDF] Top 20 Design and estimation in clinical trials with subpopulation selection

... In term of estimation we have assessed the bias of the MLE under various scenarios. We find that almost always bias is positive leading to an over-enthusiastic estimate of the true treatment effect. While for some ... See full document

... sample design. A variety of papers on treatment effect estimation in the related problem of trials with treatment selection have been ...addresses estimation issues in clinical ... See full document

... The method proposed gives uniformly minimum variance conditionally unbiased estimators in multi-arm multi-stage clinical trials. Estimators are obtained for treatment effects relative to the control for ... See full document

... routine clinical practice, then the treatment effect from the first time it is given may be a misleading representation of what will occur for the majority of times it is ...the estimation of the treatment ... See full document

... we consider and compare two methods that have been proposed to estimate the joint effects of the main treatment and the mediator/moderator. First, we consider standard regression, which has been widely used for ... See full document

... separate trials, where in the first trial, data are collected to determine if the new treatment benefits the full population or the ...separate trials, for ASDs, stage 1 data are also used in the ... See full document

... Furthermore, Morisot et al [32] investigated the interest of multiple imputation approach in the estimation of cause-specific survival notably when a subset of cause of death was available. In their case there is ... See full document

... possible selection bias introduced into clinical trials based on ability to give informed consent we analysed data from the “STRoke Adverse outcome is as- sociated WIth NoSocomial Infections” ... See full document

... controlled trials provide the best evidence, and is seen as the gold standard for allopathic ...patient selection, randomization and blind- ing, placebo effects and choice of comparator, occupational ... See full document

... lation clinical trial development for rare diseases and has provided draft guidance to assist sponsors of drugs and biological products intended to treat or prevent rare dis- eases [19] wherein strategies were ... See full document

... Several issues emerged with regard to the control regi- men. First, since the current WHO regimen is widely perceived as suboptimal, there are ethical concerns about including this as a control. Second, in some countries ... See full document

... The SCORE values described in equations 2 and 3 for all birth weights plotted so that the probability of a particular neonate’s requiring supplemental oxygen at 28 days can be read direc[r] ... See full document

... The first systematic review of RCTs of PO for the treatment of IBS was published by Pitter and Ernst in 1998, which included eight randomized trials involving 295 patients with seven of the eight trials not ... See full document

... our estimation of proportion of trials reporting run-in periods, was robust to variations in how we operationally defined “run-in ...25 trials complied with a narrower definition of the term and 11 ... See full document

... #7 ILLUMINATE—Trial terminated early due adverse effects of the CETP inhibitor. #8 CDRONA—Heart failure only patients, usually excluded from CVD trials. #9 SEAS—Simvastatin plus ezetimibe reduced all ischemic CVD ... See full document

... acceptance of TSRDs in drug development will likely hinge on the ability to make appropriate intent-to-treat type inference as to whether an experimental induction regimen is better than a standard regimen within this ... See full document

... A systematic search of cancer literature was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines in order to identify information pertaining to AYA ... See full document

... a clinical trial compared with a non-health setting. Around half of trials included in the Cochrane review were health related (patient groups, population health surveys and surveys of healthcare ... See full document

... how outcomes widely measured in adults may not be appropriate in chil- dren is in clinical trials of antihyper- tensive agents. Reduction in systolic blood pressure, which is traditionally used as the most ... See full document

... nomic Selection’ (GS), the GEBV is used to select the best parents for breeding, or to predict the performance of progeny using only genotyp- ing data without the need for phenotypic ...assisted selection ... See full document